| Controls (n = 20) | Patients (n = 40) | P |
---|---|---|---|
LV-EF (%) | 66 ± 4 | 62 ± 12 | 0.41 |
LV-EDV (ml) | 109 ± 28 | 108 ± 36 | 0.76 |
LV-ESV (ml) | 37 ± 13 | 41 ± 25 | 0.86 |
LV-SV | 71 ± 16 | 66 ± 13 | 0.41 |
LV-EDD | 45 ± 5 | 46 ± 5 | 0.67 |
LA (cm2) | 20 ± 4 | 20 ± 5 | 0.68 |
IVS (mm) | 10 ± 2 | 9 ± 3 | 0.63 |
PA (mm) | 24 ± 4 | 24 ± 6 | 0.56 |
LV mass (g) | 76 ± 18 | 82 ± 24 | 0.50 |
LGE per patient | - | 7 (18Â %) | Â |
 Epicardial | - | 1 (2 %) |  |
 Intramural | - | 6 (15 %) |  |
 Transmural | - | 1 (2 %) |  |
 Subendocardial | - | - |  |
% LV mass | - | 5.3 | Â |
Native T1 (ms) | 962 (947–987) | 1008 (990–1042) | 0.001 |
Post contrast T1 (ms) | 526 (508–553) | 494 (477–522) | 0.008 |
ECV (%) | 25 (24–27) | 28 (26–31) | 0.001 |
T2 (ms) | 49 (48–51) | 53 (52–58) | <0.001 |